Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Long Noncoding RNAs in Cancer Pathways

(2016) Adam M. Schmitt et al.   CANCER CELL

Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma

(2016) Carolin Ploeger et al.   HEPATOLOGY

Targeting transcription factor STAT3 for cancer prevention and therapy

(2016) Edna Zhi Pei Chai et al.   PHARMACOLOGY & THERAPEUTICS

Changing epidemiology of hepatocellular carcinoma in Asia

(2015) George Boon-Bee Goh et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Sugiol inhibits STAT3 activity via regulation of transketolase and ROS-mediated ERK activation in DU145 prostate carcinoma cells

(2015) Seung-Nam Jung et al.   BIOCHEMICAL PHARMACOLOGY

The tumor-suppressor gene LZTS1 suppresses hepatocellular carcinoma proliferation by impairing PI3K/Akt pathway

(2015) Yonghong He et al.   BIOMEDICINE & PHARMACOTHERAPY

The evolution of lncRNA repertoires and expression patterns in tetrapods

(2014) Anamaria Necsulea et al.   NATURE

The STAT3-Binding Long Noncoding RNA lnc-DC Controls Human Dendritic Cell Differentiation

(2014) P. Wang et al.   SCIENCE

Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt/β-Catenin signaling

(2013) Dan Xu et al.   HEPATOLOGY

Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma

(2013) Yan-feng Pan et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin

(2012) Jin-feng Huang et al.   HEPATOLOGY

Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: Potential prospects for combined targeted therapeutics

(2012) DRAZEN B. ZIMONJIC et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies

(2012) Pasquale Sansone et al.   JOURNAL OF CLINICAL ONCOLOGY

Association of Specific Genotypes in Metastatic Suppressor HTPAP with Tumor Metastasis and Clinical Prognosis in Hepatocellular Carcinoma

(2011) N. Ren et al.   CANCER RESEARCH

Integrative Genomic Identification of Genes on 8p Associated With Hepatocellular Carcinoma Progression and Patient Survival

(2011) Stephanie Roessler et al.   GASTROENTEROLOGY

Genome-wide copy number analyses identified novel cancer genes in hepatocellular carcinoma

(2011) Deshui Jia et al.   HEPATOLOGY

Inflammation and Cancer: IL-6 and STAT3 Complete the Link

(2009) Jacqueline Bromberg et al.   CANCER CELL

Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling

(2009) Jian Huang et al.   JOURNAL OF CLINICAL INVESTIGATION

Long non-coding RNAs: insights into functions

(2009) Tim R. Mercer et al.   NATURE REVIEWS GENETICS

Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis

(2008) Yutaka Midorikawa et al.   HEPATOLOGY